{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:45:21Z","timestamp":1774075521610,"version":"3.50.1"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,3,15]]},"DOI":"10.2169\/internalmedicine.5661-25","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T22:07:15Z","timestamp":1756332435000},"page":"832-839","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic Decompensation Caused by IgG4-positive Plasma Cell Infiltration Mimicking Sclerosing Cholangitis, Who Achieved a Four-year Survival by Glucocorticoid Treatment"],"prefix":"10.2169","volume":"65","author":[{"given":"Noriyo","family":"Yamashiki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University Medical Center, Japan"},{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanehiko","family":"Suwa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Yamashina","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihito","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Shimatani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ikura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kansai Medical University Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kansai Medical University Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuichi","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kansai Medical University Kori Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Naganuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kansai Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakazawa T, Naitoh I, Hayashi K, et al. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol 47: 79-87, 2012.","DOI":"10.1007\/s00535-011-0465-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Okazaki K, Uchida K, Koyabu M, Miyoshi H, Ikeura T, Takaoka M. IgG4 cholangiopathy: current concept, diagnosis, and pathogenesis. J Hepatol 61: 690-695, 2014.","DOI":"10.1016\/j.jhep.2014.04.016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28: 1193-1203, 2004.","DOI":"10.1097\/01.pas.0000136449.37936.6c"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ohara H, Okazaki K, Tsubouchi H, et al.; Research Committee of IgG4-related Diseases; Research Committee of Intractable Diseases of Liver and Biliary Tract; Ministry of Health, Labor and Welfare, Japan; Japan Biliary Association. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19: 536-542, 2012.","DOI":"10.1007\/s00534-012-0521-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ali AH, Bi Y, Machicado JD, et al. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience. J Gastroenterol 55: 1087-1097, 2020.","DOI":"10.1007\/s00535-020-01714-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhang L, Lewis JT, Abraham SC, et al. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol 34: 88-94, 2010.","DOI":"10.1097\/PAS.0b013e3181c6c09a"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Umehara H, Okazaki K, Kawa S, et al.; Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW) Japan. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31: 529-533, 2021.","DOI":"10.1080\/14397595.2020.1859710"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732-738, 2001.","DOI":"10.1056\/NEJM200103083441005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Peerani F, Du L, Lytvyak E, et al. Serum IgG4 cut-off of 70 mg\/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patients. Can Liver J 5: 31-42, 2022.","DOI":"10.3138\/canlivj-2021-0023"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 101: 2070-2075, 2006.","DOI":"10.1111\/j.1572-0241.2006.00772.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tanaka A, Tazuma S, Nakazawa T, et al. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan. J Hepatobiliary Pancreat Sci 24: 217-225, 2017.","DOI":"10.1002\/jhbp.432"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nakanuma Y, Ishizu Y, Zen Y, Harada K, Umemura T. Histopathology of IgG4-related autoimmune hepatitis and IgG4-related hepatopathy in IgG4-related disease. Semin Liver Dis 36: 229-241, 2016.","DOI":"10.1055\/s-0036-1584320"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fuke H, Shimizu A, Shiraki K. Gastric varix associated with autoimmune pancreatitis. Clin Gastroenterol Hepatol 4: xxxii, 2006.","DOI":"10.1016\/j.cgh.2006.02.014"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5661-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:33:32Z","timestamp":1774064012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5661-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5661-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"article-number":"5661-25"}}